Soleus Capital Management, L.P
$2.5B Assets Reported
118 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| KRYS | KRYSTAL BIOTECH INC | 1,153,087 | $298M | 12.1% |
| CELC | CELCUITY INC | 1,284,378 | $147M | 5.9% |
| TGTX | TG THERAPEUTICS INC | 4,029,319 | $134M | 5.4% |
| PODD | INSULET CORP | 562,500 | $118M | 4.8% |
| NVCR | NOVOCURE LTD | 10,492,391 | $114M | 4.6% |
| UTHR | UNITED THERAPEUTICS CORP DEL | 187,187 | $111M | 4.5% |
| PRAX | PRAXIS PRECISION MEDICINES I | 330,517 | $106M | 4.3% |
| VCEL | VERICEL CORP | 2,549,079 | $82M | 3.3% |
| ALKS | ALKERMES PLC | 1,970,864 | $70M | 2.8% |
| ANIP | ANI PHARMACEUTICALS INC | 820,243 | $63M | 2.6% |
Track Soleus Capital Management, L.P's 13F portfolio: $2.5B in reported holdings, 118 positions. Top holdings, AUM, and quarterly changes on SentiSense.